Novo Nordisk isn’t putting all of its weight loss drug hopes in the same basket. Its acquisition of Inversago Pharma for up to $1 billion will bring a biotech whose lead drug candidate has early clinical trial data showing significant weight loss.
Biotech startup Congruence Therapeutics is developing novel drugs that treat disease by stabilizing misfolded proteins. Key to the company’s approach is a computational platform that discovers and designs these small molecule stabilizers.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
RA Capital led Ventus Therapeutics' Series B financing, which the startup will use to develop its pipeline of medicines for “undruggable” disease targets. CEO Marcelo Bigal said the cash also gives Ventus the flexibility to consider an IPO.
Ananda Devices CEO talks about plans for expanding its organ-on-a-chip tech from researching spinal cord injuries to neurological diseases such as multiple sclerosis.
Today it was announced that Valeant CEO Mike Pearson is officially walking away from his position with the pharmaceutical company, though he will stay on board until a replacement is established.
The Canadian Space Agency has inked a deal with med tech company Hexoskin to develop wearables with an eye to supporting remote monitoring of their astronauts' vital signs in space.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Among the areas its remote physical therapy tracking platform targets are patients recovering from stroke, hip replacement, hip fractures and knee replacement.
Invented by two outdoors enthusiasts-turned-dads, Hoko, which comes with an activities book, is supposed to make sure children are comfortable so parents can plan family adventures without being interrupted by crying or tantrums. Our warped minds had other thoughts.
https://www.youtube.com/watch?v=gfWK4kauemA Digital health company Jintronix is in the midst of fundraising for a Series A round to more than double the size of its staff and scale its interactive physical therapy platform. CEO and co-founder Daniel Schacter mentioned the fundraise while participating in a panel discussion on technology and digital innovation at the annual Wharton […]